Pages that link to "Q34285654"

The following pages link to High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage (Q34285654):

Displaying 50 items.

• Pathogenesis of osteoporosis: concepts, conflicts, and prospects (Q24536164) ‎ (← links)
• Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA (Q24641909) ‎ (← links)
• Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer (Q24654971) ‎ (← links)
• Role of Nrf2 in bone metabolism (Q26778148) ‎ (← links)
• Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally (Q27919716) ‎ (← links)
• Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells (Q28236662) ‎ (← links)
• NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2 (Q28251073) ‎ (← links)
• Regulation of adult bone turnover by sex steroids (Q28281007) ‎ (← links)
• A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2 (Q28505869) ‎ (← links)
• The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation (Q28586194) ‎ (← links)
• Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter (Q28593503) ‎ (← links)
• SP7 inhibits osteoblast differentiation at a late stage in mice (Q28731578) ‎ (← links)
• The evolutionary origin of the Runx/CBFbeta transcription factors--studies of the most basal metazoans (Q28757287) ‎ (← links)
• Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures (Q30476509) ‎ (← links)
• Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation. (Q33325623) ‎ (← links)
• RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries (Q33780229) ‎ (← links)
• TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts (Q33894869) ‎ (← links)
• Hyperosmotic Stimulus Down-regulates 1alpha, 25-dihydroxyvitamin D(3)-induced Osteoclastogenesis by Suppressing the RANKL Expression in a Co-culture System (Q33988357) ‎ (← links)
• Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics (Q34265045) ‎ (← links)
• Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice (Q34333682) ‎ (← links)
• A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program (Q34358969) ‎ (← links)
• The Role of RUNX2 in Osteosarcoma Oncogenesis (Q34423871) ‎ (← links)
• The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors (Q34428195) ‎ (← links)
• Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity (Q34439684) ‎ (← links)
• Evaluating age-associated phenotypes in a mouse model of protein dyshomeostasis (Q34672553) ‎ (← links)
• Runx2 activity in committed osteoblasts is not essential for embryonic skeletogenesis. (Q34722607) ‎ (← links)
• Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis. (Q34790965) ‎ (← links)
• Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer (Q35071181) ‎ (← links)
• Comparative characteristics of porous bioceramics for an osteogenic response in vitro and in vivo (Q35082897) ‎ (← links)
• Control of osteoblast function and regulation of bone mass (Q35128237) ‎ (← links)
• Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association (Q35287635) ‎ (← links)
• Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties. (Q35737205) ‎ (← links)
• Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo (Q35757224) ‎ (← links)
• Effects of icariin on orthodontic tooth movement in rats (Q35959048) ‎ (← links)
• Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development (Q35985042) ‎ (← links)
• Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo (Q36103227) ‎ (← links)
• p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling (Q36116766) ‎ (← links)
• Runx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes (Q36246941) ‎ (← links)
• Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus (Q36513158) ‎ (← links)
• Assessment of bone mineral and matrix using backscatter electron imaging and FTIR imaging. (Q36527965) ‎ (← links)
• Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2. (Q36595115) ‎ (← links)
• Runx2 and dental development (Q36616577) ‎ (← links)
• Osteoblast-targeted overexpression of TAZ increases bone mass in vivo (Q36618804) ‎ (← links)
• Networks and hubs for the transcriptional control of osteoblastogenesis. (Q36628270) ‎ (← links)
• The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines (Q36672392) ‎ (← links)
• Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice (Q36710174) ‎ (← links)
• Gas7 is required for mesenchymal stem cell-derived bone development (Q36950478) ‎ (← links)
• 1,25-Dihydroxyvitamin D3 activates MMP13 gene expression in chondrocytes through p38 MARK pathway (Q37001533) ‎ (← links)
• Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation (Q37026949) ‎ (← links)
• Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma (Q37027406) ‎ (← links)